Literature DB >> 33510349

Oxycodone self-administration activates the mitogen-activated protein kinase/ mitogen- and stress-activated protein kinase (MAPK-MSK) signaling pathway in the rat dorsal striatum.

Christopher A Blackwood1, Michael T McCoy1, Bruce Ladenheim1, Jean Lud Cadet2.   

Abstract

To identify signaling pathways activated by oxycodone self-administration (SA), Sprague-Dawley rats self-administered oxycodone for 20 days using short-(ShA, 3 h) and long-access (LgA, 9 h) paradigms. Animals were euthanized 2 h after SA cessation and dorsal striata were used in post-mortem molecular analyses. LgA rats escalated their oxycodone intake and separated into lower (LgA-L) or higher (LgA-H) oxycodone takers. LgA-H rats showed increased striatal protein phosphorylation of ERK1/2 and MSK1/2. Histone H3, phosphorylated at serine 10 and acetylated at lysine 14 (H3S10pK14Ac), a MSK1/2 target, showed increased abundance only in LgA-H rats. RT-qPCR analyses revealed increased AMPA receptor subunits, GluA2 and GluA3 mRNAs, in the LgA-H rats. GluA3, but not GluA2, mRNA expression correlated positively with changes in pMSK1/2 and H3S10pK14Ac. These findings suggest that escalated oxycodone SA results in MSK1/2-dependent histone phosphorylation and increases in striatal gene expression. These observations offer potential avenues for interventions against oxycodone addiction.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33510349      PMCID: PMC7843984          DOI: 10.1038/s41598-021-82206-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  89 in total

1.  Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.

Authors:  Theodore J Cicero; James A Inciardi; Alvaro Muñoz
Journal:  J Pain       Date:  2005-10       Impact factor: 5.820

Review 2.  Treatment of Opioid-Use Disorders.

Authors:  Marc A Schuckit
Journal:  N Engl J Med       Date:  2016-07-28       Impact factor: 91.245

Review 3.  The Opioid Epidemic: Crisis and Solutions.

Authors:  Phil Skolnick
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-10-02       Impact factor: 13.820

4.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

Authors:  Rose A Rudd; Puja Seth; Felicita David; Lawrence Scholl
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-30       Impact factor: 17.586

Review 5.  Oxycodone for neuropathic pain in adults.

Authors:  Helen Gaskell; Sheena Derry; Cathy Stannard; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2016-07-28

6.  The promotion and marketing of oxycontin: commercial triumph, public health tragedy.

Authors:  Art Van Zee
Journal:  Am J Public Health       Date:  2008-09-17       Impact factor: 9.308

Review 7.  Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic.

Authors:  Rajiv Balyan; David Hahn; Henry Huang; Vidya Chidambaran
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-02-24       Impact factor: 4.481

Review 8.  Oxycodone for cancer-related pain.

Authors:  Mia Schmidt-Hansen; Michael I Bennett; Stephanie Arnold; Nathan Bromham; Jennifer S Hilgart
Journal:  Cochrane Database Syst Rev       Date:  2017-08-22

9.  Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016.

Authors:  Puja Seth; Lawrence Scholl; Rose A Rudd; Sarah Bacon
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-03-30       Impact factor: 17.586

Review 10.  Neuropsychological Consequences of Chronic Drug Use: Relevance to Treatment Approaches.

Authors:  Jean Lud Cadet; Veronica Bisagno
Journal:  Front Psychiatry       Date:  2016-01-15       Impact factor: 4.157

View more
  2 in total

1.  The molecular neurobiology and neuropathology of opioid use disorder.

Authors:  Christopher A Blackwood; Jean Lud Cadet
Journal:  Curr Res Neurobiol       Date:  2021-10-14

2.  Convergence of case-specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose.

Authors:  Olivia Corradin; Richard Sallari; An T Hoang; Bibi S Kassim; Gabriella Ben Hutta; Lizette Cuoto; Bryan C Quach; Katreya Lovrenert; Cameron Hays; Berkley E Gryder; Marina Iskhakova; Hannah Cates; Yanwei Song; Cynthia F Bartels; Dana B Hancock; Deborah C Mash; Eric O Johnson; Schahram Akbarian; Peter C Scacheri
Journal:  Mol Psychiatry       Date:  2022-03-17       Impact factor: 13.437

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.